Basis: Current FMP quote-based enterprise value / four-quarter operating income plus matched D&A. Source: stored company filings and market data; unavailable inputs remain N/A.
The EV/EBITDA ratio is N/A as of 2026-10-02T22:30:55.539Z.
Calculation as of: 2026-10-02T22:30:55.539Z.
Quote observation: 2026-10-02T20:00:01.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: ec086e1d6be783f280e9bc6e9de352b1fd18271fbc72e81c179235df88dabfa7
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2022-08-08.
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/EBITDA RATIO
N/A
EV/EBITDA RATIO AVG TTM
12.99x
EV/EBITDA RATIO AVG 3Y
N/A
EV/EBITDA RATIO AVG 5Y
N/A
EV/EBITDA RATIO AVG 10Y
N/A
EV/EBITDA RATIO AVG 15Y
N/A
EV/EBITDA RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Market Cap
$5.10B
EV/EBITDA Ratio
16.22x
TTM Avg
15.99x
3Y Avg
19.94x
5Y Avg
21.75x
Market Cap
$5.61B
EV/EBITDA Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$6.47B
EV/EBITDA Ratio
N/A
TTM Avg
64.66x
3Y Avg
316.14x
5Y Avg
316.14x
Market Cap
$6.63B
EV/EBITDA Ratio
16.65x
TTM Avg
15.73x
3Y Avg
18.79x
5Y Avg
18.87x
Market Cap
$2.76B
EV/EBITDA Ratio
26.71x
TTM Avg
36.07x
3Y Avg
85.76x
5Y Avg
85.76x
Market Cap
$8.02B
EV/EBITDA Ratio
6.71x
TTM Avg
75.52x
3Y Avg
49.67x
5Y Avg
49.67x
| NAME | MARKET CAP | EV/EBITDA RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| CRISPR Therapeutics AG (CRSP) | $5.35B | N/A | 12.99x | N/A | N/A |
| Doximity, Inc. (DOCS)vs › | $5.22B | 23.44x | 26.32x | 37.18x | 52.06x |
| Merit Medical Systems, Inc. (MMSI)vs › | $5.10B | 16.22x | 15.99x | 19.94x | 21.75x |
| Scholar Rock Holding Corporation (SRRK)vs › | $5.61B | N/A | N/A | N/A | N/A |
| Hims & Hers Health, Inc. (HIMS)vs › | $6.47B | N/A | 64.66x | 316.14x | 316.14x |
| Chemed Corporation (CHE)vs › | $6.63B | 16.65x | 15.73x | 18.79x | 18.87x |
| TransMedics Group, Inc. (TMDX)vs › | $2.76B | 26.71x | 36.07x | 85.76x | 85.76x |
| Oscar Health, Inc. (OSCR)vs › | $8.02B | 6.71x | 75.52x | 49.67x | 49.67x |
| Beam Therapeutics Inc. (BEAM)vs › | $2.52B | N/A | N/A | N/A | N/A |
| Recursion Pharmaceuticals, Inc. (RXRX)vs › | $2.16B | N/A | N/A | N/A | N/A |
EV/EBITDA = Enterprise Value / EBITDA (TTM)
Enterprise value to EBITDA is a capital-structure-neutral valuation multiple, useful for comparing companies with different debt levels and tax rates.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EV/EBITDA RATIO |
|---|---|
| 2022-08-08 | 17.49x |
| 2022-08-05 | 17.49x |
| 2022-08-04 | 16.91x |
| 2022-08-03 | 16.84x |
| 2022-08-02 | 16.32x |
| 2022-08-01 | 15.78x |
| 2022-07-29 | 16.01x |
| 2022-07-28 | 16.22x |
| 2022-07-27 | 16.92x |
| 2022-07-26 | 16.50x |
| 2022-07-25 | 16.36x |
| 2022-07-22 | 16.20x |
| 2022-07-21 | 17.16x |
| 2022-07-20 | 17.71x |
| 2022-07-19 | 18.04x |
| 2022-07-18 | 17.02x |
| 2022-07-15 | 17.95x |
| 2022-07-14 | 17.61x |
| 2022-07-13 | 17.33x |
| 2022-07-12 | 16.95x |
| 2022-07-11 | 15.71x |
| 2022-07-08 | 16.40x |
| 2022-07-07 | 16.75x |
| 2022-07-06 | 15.48x |
| 2022-07-05 | 14.99x |
| 2022-07-01 | 13.42x |
| 2022-06-30 | 12.72x |
| 2022-06-29 | 13.24x |
| 2022-06-28 | 13.30x |
| 2022-06-27 | 14.14x |
| 2022-06-24 | 14.15x |
| 2022-06-23 | 13.73x |
| 2022-06-22 | 12.53x |
| 2022-06-21 | 13.62x |
| 2022-06-17 | 14.85x |
| 2022-06-16 | 13.61x |
| 2022-06-15 | 13.16x |
| 2022-06-14 | 12.10x |
| 2022-06-13 | 11.45x |
| 2022-06-10 | 13.41x |
| 2022-06-09 | 15.25x |
| 2022-06-08 | 15.74x |
| 2022-06-07 | 14.63x |
| 2022-06-06 | 13.52x |
| 2022-06-03 | 13.51x |
| 2022-06-02 | 12.77x |
| 2022-06-01 | 12.05x |
| 2022-05-31 | 12.09x |
| 2022-05-27 | 12.16x |
| 2022-05-26 | 11.44x |
| 2022-05-25 | 11.28x |
| 2022-05-24 | 10.78x |
| 2022-05-23 | 11.32x |
| 2022-05-20 | 11.69x |
| 2022-05-19 | 11.73x |
| 2022-05-18 | 11.33x |
| 2022-05-17 | 11.24x |
| 2022-05-16 | 10.58x |
| 2022-05-13 | 10.74x |
| 2022-05-12 | 9.43x |
| 2022-05-11 | 8.76x |
| 2022-05-10 | 9.61x |
| 2022-05-09 | 6.68x |
| 2022-05-06 | 7.62x |
| 2022-05-05 | 8.27x |
| 2022-05-04 | 9.11x |
| 2022-05-03 | 8.52x |
| 2022-05-02 | 8.39x |
| 2022-04-29 | 7.93x |
| 2022-04-28 | 8.32x |
| 2022-04-27 | 8.39x |
| 2022-04-26 | 8.55x |
| 2022-04-25 | 9.43x |
| 2022-04-22 | 9.12x |
| 2022-04-21 | 9.09x |
| 2022-04-20 | 9.49x |
| 2022-04-19 | 9.76x |
| 2022-04-18 | 9.72x |
| 2022-04-14 | 10.39x |
| 2022-04-13 | 11.11x |
| 2022-04-12 | 10.86x |
| 2022-04-11 | 10.25x |
| 2022-04-08 | 10.28x |
| 2022-04-07 | 10.74x |
| 2022-04-06 | 11.16x |
| 2022-04-05 | 11.43x |
| 2022-04-04 | 11.83x |
| 2022-04-01 | 11.17x |
| 2022-03-31 | 10.51x |
| 2022-03-30 | 10.76x |
| 2022-03-29 | 11.13x |
| 2022-03-28 | 10.52x |
| 2022-03-25 | 10.38x |
| 2022-03-24 | 10.83x |
| 2022-03-23 | 10.66x |
| 2022-03-22 | 11.43x |
| 2022-03-21 | 11.07x |
| 2022-03-18 | 11.51x |
| 2022-03-17 | 11.43x |
| 2022-03-16 | 11.05x |
| 2022-03-15 | 9.97x |
| 2022-03-14 | 9.58x |
| 2022-03-11 | 10.24x |
| 2022-03-10 | 10.44x |
| 2022-03-09 | 10.44x |
| 2022-03-08 | 10.03x |
| 2022-03-07 | 9.02x |
| 2022-03-04 | 8.63x |
| 2022-03-03 | 8.83x |
| 2022-03-02 | 9.73x |
| 2022-03-01 | 9.46x |
| 2022-02-28 | 10.23x |
| 2022-02-25 | 9.91x |
| 2022-02-24 | 9.41x |
| 2022-02-23 | 8.64x |
| 2022-02-22 | 9.11x |
| 2022-02-18 | 9.63x |
| 2022-02-17 | 9.69x |
| 2022-02-16 | 10.35x |
| 2022-02-15 | 9.03x |
| 2022-02-14 | 8.61x |
| 2022-02-11 | 8.75x |
| 2022-02-10 | 9.20x |
| 2022-02-09 | 9.76x |
| 2022-02-08 | 9.04x |
| 2022-02-07 | 9.28x |
| 2022-02-04 | 9.20x |
| 2022-02-03 | 8.93x |
| 2022-02-02 | 9.24x |
| 2022-02-01 | 9.85x |
| 2022-01-31 | 9.53x |
| 2022-01-28 | 8.68x |
| 2022-01-27 | 8.64x |
| 2022-01-26 | 9.19x |
| 2022-01-25 | 9.31x |
| 2022-01-24 | 8.90x |
| 2022-01-21 | 9.33x |
| 2022-01-20 | 9.64x |
| 2022-01-19 | 9.61x |
| 2022-01-18 | 9.76x |
| 2022-01-14 | 10.25x |
| 2022-01-13 | 10.01x |
| 2022-01-12 | 10.63x |
| 2022-01-11 | 11.14x |
| 2022-01-10 | 10.49x |
| 2022-01-07 | 10.23x |
| 2022-01-06 | 10.14x |
| 2022-01-05 | 10.47x |
| 2022-01-04 | 11.23x |
| 2022-01-03 | 12.31x |
| 2021-12-31 | 11.69x |
| 2021-12-30 | 12.24x |
| 2021-12-29 | 11.86x |
| 2021-12-28 | 11.86x |
| 2021-12-27 | 11.90x |
| 2021-12-23 | 12.83x |
| 2021-12-22 | 12.72x |
| 2021-12-21 | 12.43x |
| 2021-12-20 | 12.63x |
| 2021-12-17 | 12.93x |
| 2021-12-16 | 11.81x |
| 2021-12-15 | 12.24x |
| 2021-12-14 | 11.47x |
| 2021-12-13 | 11.19x |
| 2021-12-10 | 11.30x |
| 2021-12-09 | 11.63x |
| 2021-12-08 | 12.34x |
| 2021-12-07 | 12.15x |
| 2021-12-06 | 10.85x |
| 2021-12-03 | 10.67x |
| 2021-12-02 | 11.88x |
| 2021-12-01 | 11.60x |
| 2021-11-30 | 12.42x |
| 2021-11-29 | 12.08x |
| 2021-11-26 | 12.23x |
| 2021-11-24 | 12.61x |
| 2021-11-23 | 12.46x |
| 2021-11-22 | 12.55x |
| 2021-11-19 | 12.88x |
| 2021-11-18 | 12.97x |
| 2021-11-17 | 13.53x |
| 2021-11-16 | 13.62x |
| 2021-11-15 | 13.35x |
| 2021-11-12 | 14.04x |
| 2021-11-11 | 13.86x |
| 2021-11-10 | 13.80x |
| 2021-11-09 | 14.46x |
| 2021-11-08 | 14.98x |
| 2021-11-05 | 14.28x |
| 2021-11-04 | 14.77x |
| 2021-11-03 | 13.80x |
| 2021-11-02 | 13.62x |
| 2021-11-01 | 13.56x |
| 2021-10-29 | 12.83x |
| 2021-10-28 | 13.30x |
| 2021-10-27 | 13.09x |
| 2021-10-26 | 13.49x |
| 2021-10-25 | 13.77x |
| 2021-10-22 | 13.57x |
| 2021-10-21 | 13.84x |
| 2021-10-20 | 14.06x |
| 2021-10-19 | 14.40x |
| 2021-10-18 | 13.69x |
| 2021-10-15 | 13.82x |
| 2021-10-14 | 14.12x |
| 2021-10-13 | 13.78x |
| 2021-10-12 | 14.80x |
| 2021-10-11 | 14.46x |
| 2021-10-08 | 14.11x |
| 2021-10-07 | 14.87x |
| 2021-10-06 | 14.70x |
| 2021-10-05 | 14.79x |
| 2021-10-04 | 14.78x |
| 2021-10-01 | 16.33x |
| 2021-09-30 | 16.44x |
| 2021-09-29 | 16.14x |
| 2021-09-28 | 16.48x |
| 2021-09-27 | 17.37x |
| 2021-09-24 | 17.23x |
| 2021-09-23 | 18.07x |
| 2021-09-22 | 17.47x |
| 2021-09-21 | 17.37x |
| 2021-09-20 | 17.24x |
| 2021-09-17 | 18.65x |
| 2021-09-16 | 17.40x |
| 2021-09-15 | 17.37x |
| 2021-09-14 | 17.21x |
| 2021-09-13 | 17.50x |
| 2021-09-10 | 17.98x |
| 2021-09-09 | 18.11x |
| 2021-09-08 | 17.72x |
| 2021-09-07 | 17.94x |
| 2021-09-03 | 18.20x |
| 2021-09-02 | 19.09x |
| 2021-09-01 | 18.97x |
| 2021-08-31 | 18.72x |
| 2021-08-30 | 17.98x |
| 2021-08-27 | 18.52x |
| 2021-08-26 | 18.19x |
| 2021-08-25 | 18.87x |
| 2021-08-24 | 18.99x |
| 2021-08-23 | 18.73x |
| 2021-08-20 | 17.37x |
| 2021-08-19 | 17.29x |
| 2021-08-18 | 17.74x |
| 2021-08-17 | 17.95x |
| 2021-08-16 | 18.30x |
| 2021-08-13 | 19.04x |
| 2021-08-12 | 20.55x |
| 2021-08-11 | 20.25x |
| 2021-08-10 | 20.51x |
| 2021-08-09 | 20.98x |
| 2021-08-06 | 20.79x |
| 2021-08-05 | 20.22x |
| 2021-08-04 | 18.66x |
| 2021-08-03 | 18.10x |
| 2021-08-02 | 18.26x |
| 2021-07-30 | 18.03x |
| 2020-10-28 | 1715.69x |
| 2020-10-27 | 1788.69x |
Showing the most recent 260 of 438 data points. The chart above shows the full history.
